This review focuses on the need for a more holistic approach to endocrine therapy that considers the roles and interplay between all sources of estrogen, endogenous and environmental, and estrogen receptors, with a special focus on GPER, given its potential importance for cancer and metabolic regulation. This evidence concerns the gene GPER1 and cancer.